FDA Selects Limbic and SonderMind for TEMPO Program to Advance AI-Driven Mental Health Solutions and Medicare Integration
The U.S. Food and Drug Administration (FDA) has finalized the selection of four participants for its Total Product Lifecycle Advisory…
